The Code is Cracked: Interchangeable Biologics are Here
FDA Law
AUGUST 12, 2021
Biosimilars do provide a more affordable way for sponsors to get products onto the market—by referencing the clinical studies performed by the reference product sponsor—which, in theory, allows for the introduction of lower cost versions of expensive biologics.
Let's personalize your content